Exhibit 99.3
GRANT THORNTON LLP | October 20, 2021 | |
200 S. Sixth St. | ||
Suite 1400 | ||
Minneapolis, MN 55402 | ||
D +1 612 332 0001 | British Columbia Securities Commission | |
Alberta Securities Commission | ||
Financial and Consumer Affairs Authority of Saskatchewan | ||
The Manitoba Securities Commission | ||
Ontario Securities Commission | ||
New Brunswick Financial and Consumer Services Commission | ||
Nova Scotia Securities Commission | ||
Prince Edward Island Office of the Superintendent of Securities | ||
Superintendent of Securities (Newfoundland and Labrador) | ||
RE: ImmunoPrecise Antibodies Ltd. (the “Corporation”) | ||
We have read the notice of change of auditor (the “Notice”) of the Corporation dated October 13, 2021 and are in agreement with the statements in such Notice as it relates to Grant Thornton LLP. | ||
Very truly yours, | ||